Edge Capital Group, LLC Royalty Pharma PLC Transaction History

Edge Capital Group, LLC

  • $2.21 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 04, 2023
BUY
$32.77 - $39.4 $1.28 Million - $1.54 Million
39,117 Added 197.37%
58,936 $2.12 Million
Q4 2022

Feb 07, 2023
BUY
$39.17 - $44.04 $106,581 - $119,832
2,721 Added 15.91%
19,819 $783,000
Q3 2022

Nov 09, 2022
BUY
$39.88 - $44.65 $681,868 - $763,425
17,098 New
17,098 $687,000

Others Institutions Holding RPRX

# of Institutions
412
Shares Held
283M
Call Options Held
578K
Put Options Held
47.5K
View Full List

About Royalty Pharma plc

RPRX Quotes by TradingView
  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11.2B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Edge Capital Group, LLC Portfolio

Follow Edge Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edge Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Edge Capital Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email